Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07312604
Eligibility Criteria:
Inclusion Criteria:
* Age between 10 - 60 years.
* Evidence of recalcitrant tinea e.g. (rapid progression \& large areas affected of the body, affection of more than one family members especially females \& children, rapid relapse after treatment, suspicion of resistant T. indotineae strain by history of traveling abroad \& contact with Indians or contact with a case coming from travel \& with contact to Indians.
* Patients failed at least 2 courses of systemic antifungal therapy in the last 3 months.
* Safe contraception during the study (for females in the childbearing period).
Exclusion Criteria:
* Pregnant or lactating women, as well as women of childbearing potential not using an effective method of contraception.
* Age \<10 years or \> 60 years.
* Immunocompromised patients e.g. (uncontrolled DM or HIV patients).
* Naïve patients without previous systemic antifungal treatment.
* Unreliable patients.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
10 Years
Maximum Age:
60 Years
Study:
NCT07312604
Study Brief:
Protocol Section:
NCT07312604